Sagimet Biosciences (SGMT) Other Working Capital Changes (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly Other Working Capital Changes of -$39000.0 for Q1 2026, little changed year-over-year from -$39000.0 in Q1 2025, and down 5.41% quarter-over-quarter from -$37000.0 in Q4 2025.
Sagimet Biosciences (SGMT) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$39000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes changed 0.0% year-over-year to -$39000.0; the TTM figure through Mar 2026 stood at -$152000.0 (down 11.76% YoY), while the FY2025 annual figure was -$152000.0, down 11.76% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$39000.0, down from -$37000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $4.3 million in Q3 2024, with the low at -$3.3 million in Q4 2024.
- The 5-year median for Other Working Capital Changes is $121000.0 (2022), against an average of $206333.3.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes soared 38.89% in 2024, then slumped 77.27% in 2025.
- Sagimet Biosciences' Other Working Capital Changes stood at -$34000.0 in 2022, then dropped by 11.76% to -$38000.0 in 2023, then changed by 0.0% to -$38000.0 in 2024, then gained by 2.63% to -$37000.0 in 2025, then retreated by 5.41% to -$39000.0 in 2026.
- Business Quant data shows SGMT's Other Working Capital Changes at -$39000.0 in Q1 2026, -$37000.0 in Q4 2025, and -$37000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -39,000.00 |
| Jun 30, 2026 | -39,000.00 |
| Jun 30, 2026 | -39,000.00 |
| Mar 31, 2026 | -39,000.00 |
| Mar 31, 2026 | -39,000.00 |
| Mar 31, 2026 | -39,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | -39,000.00 |
| Mar 31, 2025 | -39,000.00 |
| Mar 31, 2025 | -39,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2024 | -38,000.00 |